What is the appropriate dose of Augmentin (amoxicillin 250 mg/5 mL + clavulanic acid 62.5 mg/5 mL) for a 4‑year‑old child weighing 16.78 kg with otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing Recommendation for Augmentin in Otitis Media

For this 4-year-old child weighing 16.78 kg with otitis media, prescribe Augmentin 90 mg/kg/day of the amoxicillin component divided into two daily doses, which equals approximately 755 mg amoxicillin per day or 7.5 mL of the 250 mg/5 mL suspension twice daily (total 15 mL/day). 1, 2

Rationale for High-Dose Amoxicillin-Clavulanate

The formulation you have (250 mg amoxicillin + 62.5 mg clavulanate per 5 mL) provides a 4:1 ratio, which is not the preferred formulation for treating otitis media in this age group. Current guidelines strongly recommend high-dose amoxicillin-clavulanate at 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate (14:1 ratio) to adequately cover penicillin-resistant Streptococcus pneumoniae and β-lactamase-producing Haemophilus influenzae. 1, 2

Specific Dosing Calculation

For a 16.78 kg child:

  • Target dose: 90 mg/kg/day amoxicillin = 1,510 mg/day
  • Divided into 2 doses: 755 mg per dose
  • Using your 250 mg/5 mL suspension: 15 mL per dose (twice daily)

However, this provides only 187.5 mg clavulanate per day (11.2 mg/kg/day), which exceeds the recommended 6.4 mg/kg/day and increases diarrhea risk. 3

Critical Formulation Issue

The ideal formulation is Augmentin ES-600 (600 mg amoxicillin + 42.9 mg clavulanate per 5 mL), which provides the 14:1 ratio. 2 For this 16.78 kg child, the ES-600 dose would be:

  • 90 mg/kg/day = 1,510 mg amoxicillin/day
  • Volume needed: 12.6 mL twice daily of ES-600 suspension

If Using Your Current Formulation (250/62.5 per 5 mL)

If ES-600 is unavailable and you must use the 250/62.5 formulation:

  • Dose: 7.5 mL twice daily (provides 750 mg amoxicillin/day = 45 mg/kg/day)
  • Duration: 10 days 1, 2
  • Limitation: This provides suboptimal coverage for resistant pneumococci

Treatment Duration and Monitoring

  • Standard duration: 10 days for children under 6 years 1, 2
  • Assess response: Clinical improvement expected within 48-72 hours 4
  • Treatment failure criteria: Lack of improvement or worsening after 48-72 hours warrants consideration of ceftriaxone (50 mg/kg IM for 3 days) 1

Important Clinical Considerations

Risk factors requiring high-dose therapy include:

  • Age under 2 years (this child is 4, so moderate risk)
  • Recent antibiotic use within 30 days
  • Daycare attendance
  • Recurrent otitis media 1, 2

Common adverse effects with the higher clavulanate ratio in your formulation:

  • Diarrhea occurs in 26-33% of children 5, 3
  • Diaper dermatitis in 21-33% 3
  • These rates are higher than with the 14:1 ratio formulation

Practical Administration

  • Give at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 2
  • Shake suspension well before each dose
  • Refrigerate after reconstitution; stable for 10 days 2
  • Monitor compliance using bottle volume measurement

Alternative if Treatment Fails

If clinical failure occurs after 48-72 hours on your current formulation:

  • Switch to: Ceftriaxone 50 mg/kg IM daily for 3 days, OR
  • Switch to: High-dose amoxicillin-clavulanate ES-600 if available 1

Bottom line: While you can use the 250/62.5 formulation at 7.5 mL twice daily, strongly consider obtaining the ES-600 formulation (14:1 ratio) for optimal efficacy against resistant pathogens and reduced side effects. The current evidence demonstrates superior clinical cure rates (86.5% vs 71%) with properly dosed high-dose amoxicillin-clavulanate compared to alternatives. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.